Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — Free Cash Flow Generation Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Free Cash Flow Generation Index of -6.61x as of December 2023. Free cash flow of CN¥-598.15 Million represents -7% of operating cash flow (CN¥90.45 Million). Explore 301096 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Free Cash Flow Generation Index (2019–2023)
Historical FCF Generation Index trend for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Hangzhou Bio-Sincerity Pharma-Tech Co.Lt.
Annual Free Cash Flow Generation for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Year-by-year Free Cash Flow Generation Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. Check 301096 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -6.61x | CN¥-598.15 Million | CN¥90.45 Million | CN¥688.60 Million | ▼ -416.4% |
| 2022 | -1.28x | CN¥-332.16 Million | CN¥259.41 Million | CN¥591.58 Million | ▼ -80.7% |
| 2021 | -0.71x | CN¥-103.02 Million | CN¥145.42 Million | CN¥248.45 Million | ▲ +80.8% |
| 2020 | -3.69x | CN¥-200.76 Million | CN¥54.36 Million | CN¥255.12 Million | ▼ -643.8% |
| 2019 | -0.50x | CN¥-35.48 Million | CN¥71.47 Million | CN¥106.95 Million | — |